PacWest Financial Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$16.5M Buy
91,810
+2,430
+3% +$44.1K 0.97% 43
2016
Q3
$1.86M Buy
89,380
+8,310
+10% +$206K 1.14% 40
2016
Q2
$2.18M Sell
81,070
-760
-0.9% -$20.8K 1.36% 23
2016
Q1
$2.22M Sell
81,830
-1,234
-1% -$33.1K 1.43% 23
2015
Q4
$2.41M Sell
83,064
-3,530
-4% -$97.7K 1.61% 19
2015
Q3
$2.35M Sell
86,594
-410
-0.5% -$11.6K 1.74% 14
2015
Q2
$2.38M Buy
87,004
+200
+0.2% +$5.62K 1.68% 15
2015
Q1
$2.32M Buy
86,804
+2,100
+2% +$48.4K 1.64% 15
2014
Q4
$1.79M Buy
84,704
+1,900
+2% +$42.4K 1.27% 31
2014
Q3
$1.97M Sell
82,804
-3,030
-4% -$69.7K 1.47% 21
2014
Q2
$1.98M Sell
85,834
-416
-0.5% -$9.19K 1.47% 22
2014
Q1
$1.97M Buy
86,250
+1,350
+2% +$28.8K 1.53% 20
2013
Q4
$1.57K Sell
84,900
-4,770
-5% -$83.1K 0.47% 33
2013
Q3
$1.52M Buy
89,670
+650
+0.7% +$10.9K 1.31% 31
2013
Q2
$1.38M Buy
+89,020
New +$1.48M 1.31% 31

Other funds holding NVO

PacWest Financial Management's NVO Position: Q4 2016 in Review

PacWest Financial Management increased its Novo Nordisk (NVO) stake by 2.7% in Q4 2016, buying an estimated $44.1K and bringing the position to 91,810 shares worth $16.5M. The position accounts for 0.97% of the portfolio, ranked #43.

PacWest Financial Management first reported a position in NVO in Q2 2013 and has held it in 15 quarters since. 483 funds tracked by Wall St. Rank hold NVO as of Q4 2016.

  • PacWest Financial Management held 91,810 shares of Novo Nordisk worth $16.5M as of Q4 2016.
  • PacWest Financial Management bought 2,430 Novo Nordisk shares in Q4 2016, an estimated $44.1K.
  • Novo Nordisk made up 0.97% of PacWest Financial Management's portfolio in Q4 2016, its #43 holding.
  • PacWest Financial Management first reported a position in Novo Nordisk in Q2 2013 and has held it in 15 quarters since.
  • 483 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2016.

Based on PacWest Financial Management's 13F filing for Q4 2016, filed 10 Jan 2017.